Screening effective target sites on mRNA

A ribozyme library approach

Hoshang J. Unwalla, John J. Rossi

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Hammerhead ribozymes have been extensively used as RNA-inactivating agents for therapy as well as forward genomics. A ribozyme can be designed so as to specifically pair with virtually any target RNA, and cleave the phosphodiester backbone at a specified location, thereby functionally inactivating the RNA. Two major factors that determine whether ribozymes will be effective for posttranscriptional gene silencing are colocalization of the ribozyme and the target RNAs, and the choice of an appropriate target site on the mRNA. Complex secondary structures and the ability to bind to some of the cellular proteins mandate that some RNA sequences could stearically occlude binding of RNA-based antivirals like ribozymes to these sites. The use of ribozyme libraries in cell culture factors in these interactions to select for target sites on the RNA, which are more accessible to RNA-based antivirals like ribozymes or siRNA. This chapter provides a useful guide toward using ribozyme libraries to screen for effective target sites on mRNA.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
Pages329-336
Number of pages8
Volume848
DOIs
StatePublished - Mar 19 2012

Publication series

NameMethods in Molecular Biology
Volume848
ISSN (Print)10643745

Fingerprint

Catalytic RNA
RNA
Messenger RNA
Antiviral Agents
Genomics
RNA Interference
Small Interfering RNA
Cell Culture Techniques

Keywords

  • Antiviral
  • Gene Expression
  • Hammerhead Ribozyme
  • mRNA cleavage
  • Target Site Selection
  • Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Unwalla, H. J., & Rossi, J. J. (2012). Screening effective target sites on mRNA: A ribozyme library approach. In Methods in Molecular Biology (Vol. 848, pp. 329-336). (Methods in Molecular Biology; Vol. 848). https://doi.org/10.1007/978-1-61779-545-9_20

Screening effective target sites on mRNA : A ribozyme library approach. / Unwalla, Hoshang J.; Rossi, John J.

Methods in Molecular Biology. Vol. 848 2012. p. 329-336 (Methods in Molecular Biology; Vol. 848).

Research output: Chapter in Book/Report/Conference proceedingChapter

Unwalla, HJ & Rossi, JJ 2012, Screening effective target sites on mRNA: A ribozyme library approach. in Methods in Molecular Biology. vol. 848, Methods in Molecular Biology, vol. 848, pp. 329-336. https://doi.org/10.1007/978-1-61779-545-9_20
Unwalla HJ, Rossi JJ. Screening effective target sites on mRNA: A ribozyme library approach. In Methods in Molecular Biology. Vol. 848. 2012. p. 329-336. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-61779-545-9_20
Unwalla, Hoshang J. ; Rossi, John J. / Screening effective target sites on mRNA : A ribozyme library approach. Methods in Molecular Biology. Vol. 848 2012. pp. 329-336 (Methods in Molecular Biology).
@inbook{3b00de2ff13b4fc69af8e4ad14137e0c,
title = "Screening effective target sites on mRNA: A ribozyme library approach",
abstract = "Hammerhead ribozymes have been extensively used as RNA-inactivating agents for therapy as well as forward genomics. A ribozyme can be designed so as to specifically pair with virtually any target RNA, and cleave the phosphodiester backbone at a specified location, thereby functionally inactivating the RNA. Two major factors that determine whether ribozymes will be effective for posttranscriptional gene silencing are colocalization of the ribozyme and the target RNAs, and the choice of an appropriate target site on the mRNA. Complex secondary structures and the ability to bind to some of the cellular proteins mandate that some RNA sequences could stearically occlude binding of RNA-based antivirals like ribozymes to these sites. The use of ribozyme libraries in cell culture factors in these interactions to select for target sites on the RNA, which are more accessible to RNA-based antivirals like ribozymes or siRNA. This chapter provides a useful guide toward using ribozyme libraries to screen for effective target sites on mRNA.",
keywords = "Antiviral, Gene Expression, Hammerhead Ribozyme, mRNA cleavage, Target Site Selection, Therapeutics",
author = "Unwalla, {Hoshang J.} and Rossi, {John J.}",
year = "2012",
month = "3",
day = "19",
doi = "10.1007/978-1-61779-545-9_20",
language = "English",
isbn = "9781617795442",
volume = "848",
series = "Methods in Molecular Biology",
pages = "329--336",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Screening effective target sites on mRNA

T2 - A ribozyme library approach

AU - Unwalla, Hoshang J.

AU - Rossi, John J.

PY - 2012/3/19

Y1 - 2012/3/19

N2 - Hammerhead ribozymes have been extensively used as RNA-inactivating agents for therapy as well as forward genomics. A ribozyme can be designed so as to specifically pair with virtually any target RNA, and cleave the phosphodiester backbone at a specified location, thereby functionally inactivating the RNA. Two major factors that determine whether ribozymes will be effective for posttranscriptional gene silencing are colocalization of the ribozyme and the target RNAs, and the choice of an appropriate target site on the mRNA. Complex secondary structures and the ability to bind to some of the cellular proteins mandate that some RNA sequences could stearically occlude binding of RNA-based antivirals like ribozymes to these sites. The use of ribozyme libraries in cell culture factors in these interactions to select for target sites on the RNA, which are more accessible to RNA-based antivirals like ribozymes or siRNA. This chapter provides a useful guide toward using ribozyme libraries to screen for effective target sites on mRNA.

AB - Hammerhead ribozymes have been extensively used as RNA-inactivating agents for therapy as well as forward genomics. A ribozyme can be designed so as to specifically pair with virtually any target RNA, and cleave the phosphodiester backbone at a specified location, thereby functionally inactivating the RNA. Two major factors that determine whether ribozymes will be effective for posttranscriptional gene silencing are colocalization of the ribozyme and the target RNAs, and the choice of an appropriate target site on the mRNA. Complex secondary structures and the ability to bind to some of the cellular proteins mandate that some RNA sequences could stearically occlude binding of RNA-based antivirals like ribozymes to these sites. The use of ribozyme libraries in cell culture factors in these interactions to select for target sites on the RNA, which are more accessible to RNA-based antivirals like ribozymes or siRNA. This chapter provides a useful guide toward using ribozyme libraries to screen for effective target sites on mRNA.

KW - Antiviral

KW - Gene Expression

KW - Hammerhead Ribozyme

KW - mRNA cleavage

KW - Target Site Selection

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=84858254434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858254434&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-545-9_20

DO - 10.1007/978-1-61779-545-9_20

M3 - Chapter

SN - 9781617795442

VL - 848

T3 - Methods in Molecular Biology

SP - 329

EP - 336

BT - Methods in Molecular Biology

ER -